{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Phoenix",
      "state": "AZ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "82421",
      "recalling_firm": "MSM Nutraceuticals, LLC",
      "address_1": "2103 W Parkside Ln Ste 107",
      "address_2": "N/A",
      "postal_code": "85027-1245",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-1128-2019",
      "product_description": "Red Eye, Eye Drops, Active Ingredients: OptiMSM, Glycerin USP, Hyaluronic Acid, Naphazolene Chloride, Net Wt. 15ml, 0.15 fl oz., Manufactured by: MSM Nutraceuticals, LLC , UPC 8 54582 00118 0",
      "product_quantity": "200 15 ml Bottles",
      "reason_for_recall": "Lack of Assurance of Sterility: Product is not terminally sterialized and not tested per USP 71.",
      "recall_initiation_date": "20190312",
      "center_classification_date": "20190415",
      "termination_date": "20230517",
      "report_date": "20190424",
      "code_info": "Lot # 1808051, Exp. Date 01/01/22"
    }
  ]
}